Tafenoquine plus standard care for babesiosis
Treatments studied
Part of Infections clinical trials.
This study tests whether adding the oral drug tafenoquine to standard care works better than standard care plus a placebo for treating babesiosis, a tick-borne illness. You must be hospitalized with active symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have a confirmed Babesia infection.
- You are currently hospitalized for babesiosis treatment and will stay in the hospital for at least the first few days of the study.
- You are willing to take oral medications and complete all study visits and assessments.
- You have not taken azithromycin or atovaquone in the past year to treat babesiosis.
- You are not pregnant and will use effective birth control if you could become pregnant.
- You have no other serious illnesses or allergies that would make it unsafe to take the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication, tafenoquine, to see if it helps people with chronic babesiosis who have ongoing fatigue and other symptoms. It aims to find a better treatment for this tick-borne infection that keeps coming back.
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
This study tests how the body processes a single dose of the antimalarial drug tafenoquine in healthy adults. It will help doctors understand how the drug works and how it is broken down, which may lead to better ways to prevent malaria.
This trial tests whether adding the drug tafenoquine to standard malaria treatment can prevent the return of P. vivax malaria. It is for adults who have a normal G6PD enzyme level and are healthy enough to participate.
This trial tests a two-drug combination to safely and quickly clear all stages of P. vivax malaria from your body. You must have confirmed vivax malaria, be within a certain weight range, and agree to hospital stay and follow-up visits over 6 months.
This study tests the best dose of tafenoquine to treat people with symptoms from a malaria type called P. vivax and to help prevent it from coming back. You may be eligible if you recently had fever and meet specific blood and safety checks, especially G6PD level.
Hear when a new Babesiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.